129 results on '"Mauch, P.M."'
Search Results
2. Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy
3. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy
4. Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma
5. A prospective study of pulmonary function in Hodgkin’s lymphoma patients
6. Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease
7. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis
8. Clinical course of thoracic cancers in Hodgkin's disease survivors
9. Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin’s disease
10. Management and Outcomes of Women Diagnosed With Primary Breast Lymphoma
11. The Impact of Radiation Field Size on Long-Term All-Cause Mortality of Stage I-II Hodgkin Lymphoma Patients
12. Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)
13. Significant Reduction in Breast Cancer Risk as Long-Term Hodgkin Lymphoma Survivors Reach Menopausal Age
14. Predictive Factors for Ophthalmic Toxicity in Patients Receiving Radiation Therapy for Ocular Adnexal or Periorbital Lymphoma
15. Favorable Outcome in Stage I-II Mantle Cell Lymphoma: A Report of 160 Patients From the International Lymphoma Radiation Oncology Group (ILROG)
16. Long-Term Competing Mortality in Early-Stage Hodgkin Lymphoma: Reduced Mortality Risk in Patients Treated in the Modern Era
17. Low-Dose Chest CT for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost-Effectiveness Analysis
18. Rates and Durability of Response to Salvage Radiation Therapy Among Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
19. Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study
20. Thyroid Malignancies in Survivors of Hodgkin Lymphoma
21. Low-dose Involved-field Radiation in the Palliation Of Non-Hodgkin Lymphoma: Predictors of Response and Treatment Failure
22. Radiotherapy for Management of Localized Primary Cutaneous B-cell Lymphoma
23. Four-Dimensional CT Planning for Gastric MALT Lymphoma
24. Lung Malignancies after Hodgkin Lymphoma: Disease Characteristics, Detection Methods and Clinical Outcome
25. A Prospective Cardiac Screening Study in Asymptomatic Long-term Survivors of Hodgkin's Lymphoma Treated with Mediastinal Radiation Therapy
26. Favorable Outcomes of Combined Modality Treatment for Non-Hodgkin Lymphoma Despite Positive Mid- or Post-chemotherapy PET
27. Salvage Radiotherapy in Patients with Recurrent or Refractory CNS Lymphoma
28. Predictors of Symptomatic Failure after Palliative Radiation Therapy for Multiple Myeloma
29. Local Progression after Low-dose Involved-field Radiation for Non-Hodgkin Lymphoma
30. Lymphocyte-predominant Hodgkin Lymphoma: Patient Outcomes from a Large Single-institution Series with Long Follow-up
31. A Prospective Study of Pulmonary Function in Hodgkin's Lymphoma Patients
32. Long-Term Risk of Cardiac Events Requiring Interventions in Survivors of Hodgkin's Lymphoma (HL) Treated With Mediastinal Irradiation
33. Response to Low-Dose Involved-Field Radiotherapy (LD-IF-RT) in Patients With Non-Hodgkin's Lymphoma (NHL)
34. Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma
35. The effect of combining cyclophosphamide with total-body irradiation on donor bone marrow engraftment
36. The impact of treatment on the risk of second malignancy after Hodgkin's disease
37. 169
38. 2524
39. 2600
40. 168
41. Long-Term Results of a Prospective Trial of Mantle Irradiation (RT) Alone for Early-Stage Hodgkin’s Disease (HD)
42. Cost-effectiveness of Routine Computerized Tomography in Follow-up of Patients with Complete Response After Primary Treatment for Hodgkin’s Disease
43. Fatigue in long-term survivors of Hodgkin’s disease is associated with underlying cardiac disease
44. Factors influencing treatment decision in early-stage Hodgkin disease: a physician survey
45. Cost-effectiveness of computerized tomography screening for lung cancer in Hodgkin’s disease survivors
46. Treatment outcome and pulmonary toxicity of ABVD chemotherapy for Hodgkin’s disease
47. Decision analysis on tamoxifen as chemoprevention for breast cancer in young women treated with radiation therapy for Hodgkin’s disease
48. Second malignancy after Hodgkin’s disease: Long-term risk and risk factors
49. Long-term survival and competing causes of death in Hodgkin's disease (HD)
50. The role of radiotherapy for early stage Hodgkin’s disease: Limitations and perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.